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Table 1: Comparison of biosensor across different growth media and sample composition 
Biosensor Growth 
condition 
Sample 
background 
Fold-
Induction 
Transfer function 
Goodness-of-fit 
Limit of 
Detection 
Sensitivity 
(Hill Slope) 
Without 
llDR 
M9 with 
glycerol 
M9 with 
glycerol 
2.02 0.905 
 
0.5 
 
1.54 
 
With lldR M9 with 
glycerol 
M9 with 
glycerol 
59.67 0.999 
 
0.05 
 
4.00 
With lldR M9 with 
glucose 
M9 with glucose 18.63 0.981 
 
0.05 
 
4.62 
With lldR M9 with 
glycerol 
D-lactate in M9 
with glycerol 
1.95 0.974 
 
0.5 
 
0.34 
With lldR M9 with 
glycerol 
pyruvate in M9 
with glycerol 
0.73 0.837 
 
0.5 
 
-11.57 
With lldR CD-CHO CD-CHO* 2.78 0.971 
 
0.2 
 
0.45 
With lldR M9 with 
glycerol 
CD-CHO  8.25 0.999 
 
0.1 
 
0.09 
With lldR M9 with 
glycerol 
CD-CHO + HT 
supplement, 8 
mM gln 
11.96 0.992 
 
0.05 0.28 
With lldR M9 with 
glycerol 
DMEM 16.75 0.771 0.001 0.66 
With lldR M9 with 
glycerol 
DMEM + phenol 
red 
23.11 0.950 
 
0.1 0.29 
With lldR M9 with 
glycerol 
DMEM + serum 7.90 0.947 0.05 0.50 
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Abstract 15 
Many high-value added recombinant proteins, such as therapeutic glycoproteins, are 16 
produced using mammalian cell cultures. In order to optimise the productivity of these 17 
cultures it is important to monitor cellular metabolism, for example the utilisation of nutrients 18 
and the accumulation of metabolic waste products.  One metabolic waste product of interest 19 
is lactic acid (lactate), overaccumulation of which can decrease cellular growth and protein 20 
production.  Current methods for the detection of lactate are limited in terms of cost, 21 
sensitivity, and robustness.  Therefore, we developed a whole-cell Escherichia coli lactate 22 
biosensor based on the lldPRD operon and successfully used it to monitor lactate 23 
concentration in mammalian cell cultures.  Using real samples and analytical validation we 24 
demonstrate that our biosensor can be used for absolute quantification of metabolites in 25 
complex samples with high accuracy, sensitivity and robustness.  Importantly, our whole-cell 26 
biosensor was able to detect lactate at concentrations more than two orders of magnitude 27 
lower than the industry standard method, making it useful for monitoring lactate 28 
concentrations in early phase culture. Given the importance of lactate in a variety of both 29 
industrial and clinical contexts we anticipate that our whole-cell biosensor can be used to 30 
address a range of interesting biological questions.  It also serves as a blueprint for how to 31 
capitalise on the wealth of genetic operons for metabolite sensing available in Nature for the 32 
development of other whole-cell biosensors. 33 
Keywords: Synthetic Biology, Whole-cell bacterial biosensor, Biopharmaceutical 34 
processing, LldPRD operon , lactate / lactic acid 35 
 36 
37 
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Introduction 38 
Biopharmaceuticals are protein-based drugs, such as monoclonal antibodies and enzymes, 39 
often with sugars attached that affect their efficacy and mechanism of action.  They include 40 
blockbuster drugs such as Humira, Avastin, and Herceptin, with the top five selling drugs 41 
generating nearly 70 billion USD in revenue in 2013 alone. Currently, biopharmaceuticals 42 
are predominantly produced using mammalian cell cultures to ensure appropriate 43 
glycosylation, with Chinese Hamster Ovary (CHO) cells the most prevalent host for the 44 
production of glycoproteins in industry today (Kyriakopoulos and Kontoravdi 2013; Walsh 45 
2014).  46 
The measurement of key metabolites during biopharmaceutical production is essential to 47 
inform the design of medium and feeds and to optimise cell culture conditions for increased 48 
productivity.  It is also routinely used to monitor and control the trajectory of cultures during 49 
production to prolong the life of cells and maximise the yield of the product (Constantinou 50 
and Polizzi 2013; Wuest et al. 2012).  One particular metabolite of interest is lactic acid 51 
(lactate), a metabolic waste product produced as a byproduct of glycolysis. High 52 
concentrations of lactate can negatively affect cell growth and productivity (Li et al. 2010; 53 
Zhou et al. 2011) and can, via acidification of the medium, cause changes in glycosylation 54 
patterns (Yoon et al. 2005).   55 
Lactate concentrations can exhibit very complicated dynamics across different culture 56 
phases as it is both produced, and later, consumed by Chinese Hamster Ovary cells (Bertels 57 
et al. 2012).  Recent work has also shown that lactate metabolism can also be an indicator 58 
of bioreactor performance during an individual run, with ability to discriminate between low 59 
and high productivity runs, even as early as the inoculum train. This suggests lactate 60 
accumulation could be a target for remedial action if cells appear to be headed towards a 61 
low productivity run.  Interestingly, the analysis suggests that interventions must occur 62 
before 70 hours into the production run to have the most chance of being successful (Le et 63 
al. 2012).   64 
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Given the importance of lactate as a metabolite, the development of biosensors to detect 65 
lactate in samples has been an active area of research.  In particular, a number of 66 
biosensors based on enzymes such as lactate dehydrogenase or lactate oxidase have been 67 
developed.  The output signals from these biosensors vary, but include spectroscopic (Shah 68 
et al. 2007), fluorescent (D'Auria et al. 2000; Li et al. 2009; Trettnak and Wolfbeis 1989), 69 
chemiluminescent (Martinez-Olmos et al. 2009; Roda et al. 2014; Zhou et al. 2014), or 70 
amperometric detection (Haccoun et al. 2006; Hasebe et al. 2005; Male et al. 1997; Parra et 71 
al. 2006; Weber et al. 2006), with the latter as the dominant detection modality (recently 72 
reviewed in (Rathee et al. 2016)). Novel methods of immobilisation to improve detection 73 
have also been explored (Haccoun et al. 2006; Hasebe et al. 2005; Pagan et al. 2015; Tu et 74 
al. 2016; Xu et al. 2005; Yang et al. 2008).  Although whole-cell biosensors for lactate have 75 
not been previously reported, San Martin et al (2013) developed a Förster Resonance 76 
Energy Transfer (FRET) protein-based biosensor, which was expressed in mammalian cells 77 
in order to directly monitor changes in intracellular lactate (San Martin et al. 2013). The 78 
disadvantage of this approach is that it requires cells to express an additional protein, which 79 
would not be desirable in a biopharmaceutical process as it may negatively impact the ability 80 
of cells to express the recombinant product. 81 
Current standard analytical methods for measuring lactate concentrations rely largely on 82 
HPLC and electrochemical methods, which are limited in terms of cost, sensitivity, and 83 
robustness (Bracewell and Polizzi 2014).  The industry standard instrument, the Bioprofile 84 
Analyzer, quantifies lactate concentration using an amperometric immobilised enzyme 85 
biosensor (Biomedical 2016).  Even though this analysis can be automated (Derfus et al. 86 
2010), a large sample volume is required (at least 1 mL) and the lower limit of detection is in 87 
the millimolar range, limiting its application to later stages of culture.  Enzymatic lactate 88 
detection kits, based on the lactate oxidase enzyme are also commercially available.  These 89 
have a higher sensitivity for detection of lactate, but are very costly, largely due to the costs 90 
associated with purification of the enzyme. 91 
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Nature offers a potential solution in the form of bacterial genetic operons, which are 92 
designed to sense the concentration of important metabolites in the environment and 93 
activate gene expression in response (Goers et al. 2013).  The sensitivity of such systems is 94 
very high—often compounds are detected at micromolar or even nanomolar concentrations 95 
(Goers et al. 2013) and a wealth of such systems that can detect important metabolites for 96 
mammalian cell culture such as sugars, amino acids, and metabolic waste products have 97 
been identified (e.g (Engels et al. 2008; Pittard et al. 2005; Senior 1975)). Therefore, 98 
bacterial genetic operons represent a rich source for designing new whole-cell biosensors 99 
for application in industrial bioprocessing. In particular, operons to utilise lactate as a carbon 100 
source have been described in E coli (Aguilera et al. 2008), Cornyebacterium (Gao et al. 101 
2008), Pseudomonas (Gao et al. 2012) and Bacillus subtilis (Chai et al. 2009).  Any of these 102 
can be used to design a whole-cell biosensor by co-opting the existing genetic elements to 103 
sense lactate and activate gene expression and using them to express a reporter protein in 104 
response to lactate induction. 105 
Research in whole-cell biosensors began in the 1970s (Ames et al. 1973), but has recently 106 
undergone a resurgence through the application of synthetic biology methodologies to 107 
rapidly and reliably engineer new sensors (van der Meer and Belkin 2010). The simplest 108 
whole-cell biosensors are microorganisms, either natural (e.g. Vibrio fischeri, which is 109 
naturally luminescent (Bulich and Isenberg 1981) or engineered (Belkin et al. 1996; 110 
Quillardet et al. 1982), used to identify the presence of toxic molecules via a disturbance in 111 
the expression of a reporter protein.  More sophisticated whole-cell biosensors can be 112 
designed to sense particular compounds of interest including heavy metals (Aleksic et al. 113 
2007; Prindle et al. 2012; Wong et al. 2015), medically relevant molecules (Auslander et al. 114 
2014), and other small molecules (Mustafi et al. 2011; Rogers et al. 2015; Tessaro et al. 115 
2012) and activate the expression of a reporter gene in response (thereby ‘lighting up’ in the 116 
presence of the analyte).  Cell arrays can be used to detect multiple compounds from the 117 
same sample or to distinguish between related compounds (Kabessa et al. 2013; Kim et al. 118 
2013).  Although they have largely been discussed in the context of sensing environmental 119 
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pollutants (Aleksic et al. 2007; Belkin 2003; Checa et al. 2012; Prindle et al. 2012), in 120 
principle, whole-cell biosensors can be designed to detect any compound of interest. Whole-121 
cell biosensors are not limited to bacteria, but can include any type of cell such as 122 
mammalian (Auslander et al. 2014; Hillger et al. 2015), plant (Wong et al. 2015), algae 123 
(Podola and Melkonian 2003), fungi (Weitz et al. 2002), etc. 124 
Whole-cell biosensors have several advantages over other types of sensing formats.  As a 125 
living organism, they are self-renewing and obviate the need for purification of enzymes, 126 
leading to low reagent costs.  They can be grown in large quantities from a single cell if 127 
required, meaning that they are portable. Crucially, because they are based on genetic 128 
operons, the sensitivity of whole-cell biosensors is often very high (Goers et al. 2013).  129 
However, applying whole-cell biosensors in complex media is difficult due to interference 130 
from other compounds in the mixture and low signal-to-noise ratios (Courbet et al. 2015).  131 
Previous reports of whole-cell biosensors often lack cross-validation with existing 132 
measurement methods (Mustafi et al. 2011) or focus on the detection of compounds in 133 
‘mock’ samples of low complexity (Prindle et al. 2012).  Moreover, to date there have been 134 
very few reports of whole-cell biosensors to measure metabolites that are also made by the 135 
biosensor host (Bertels et al. 2012; Mustafi et al. 2011; Tessaro et al. 2012).  Instead, efforts 136 
have primarily focused on the detection of exogenous compounds (e.g. heavy metals or 137 
pollutants) (Aleksic et al. 2007; Belkin 2003; Checa et al. 2012; Prindle et al. 2012) in order 138 
to avoid crosstalk with the host organism.  However, with the advent of synthetic biology 139 
tools and techniques such as rapid and cost-effective DNA assembly and automated part 140 
characterisation, it is now possible to design biosensor variants where cross-talk with 141 
endogenous metabolites is minimised (Wang et al. 2013). 142 
The application of whole-cell biosensors to bioprocess monitoring would require 143 
quantification of the concentration of metabolites as obtained by the Bioprofile Analyser, 144 
HPLC and other analytical methods.  However, this type of characterisation is not routinely 145 
conducted in the development of new biosensors and is complicated by the complexity of the 146 
sample background.  Using iterative cycles of characterisation in increasingly complex 147 
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environments, we developed a workflow to achieve robust quantification of lactate in 148 
mammalian cell culture samples.  Crucially, we used automation to control the environment, 149 
which will increase reproducibility and limit the effects of crosstalk with the host organism by 150 
keeping cells in the same metabolic state across different experiments.  We used two 151 
genetic variations of the natural E. coli lldPRD lactate operon (Figure 1) to construct our 152 
biosensor and tested its performance in a wide range of conditions.  We were able to 153 
demonstrate that our whole-cell bacterial biosensor shows a measurable response to lactate 154 
in a variety of different cell culture media. Further, we show that the concentration of lactate 155 
in real cell culture samples can be accurately quantified when validated against existing 156 
analytical methods. Finally, our biosensor has a lower limit of detection than the Bioprofile 157 
Analyser and is less expensive per sample analysed than commercially available lactate 158 
oxidase assay kits. Therefore, it can be used for routine monitoring of cell culture 159 
trajectories, even in early phases of culture where lactate concentrations may be less than 1 160 
mM. 161 
 162 
Materials and Methods 163 
Molecular Biology 164 
E. coli DH5α (α-Select, Bioline) cells were used for expression and characterisation of all 165 
bacterial constructs.  All plasmids were based on the pSB1A2 plasmid backbone and pre-166 
existing BioBrick parts were obtained from the distributions of the iGEM Registry of Standard 167 
Biological Parts (partsregistry.org). The lldPRD promoter and the lldR gene (Supplementary 168 
Table 1) were amplified from the E. coli genome via PCR using the primers listed in 169 
Supplementary Table 2, which incorporate the BioBrick prefix and suffix.  Constructs were 170 
assembled using the BioBrick Assembly standard. Plasmids were verified by DNA 171 
sequencing (Source Biosciences).  172 
Biosensor Characterisation 173 
Biosensors were characterized using an Aviso-GmbH Theonyx robotic platform linked to a 174 
plate reader (Synergy HT, Biotek) and a shaking incubator (Ventura 2000, Mikura). Single 175 
Page 8 of 40
John Wiley & Sons
Biotechnology & Bioengineering
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
8 
 
colonies containing the biosensor plasmid or a control plasmid lacking the lldPRD promoter 176 
were used to inoculate 1 ml of LB medium containing 100 µg/mL ampicillin (Sigma Aldrich) 177 
and grown for approximately 6 hours during the day at 37°C with shaking at 250 rpm. The 178 
starter culture was diluted 1:100 into 5 ml of M9 minimal medium (1x M9 salts, 2 mM 179 
MgSO4, 0.1 mM CaCl2, 0.34 g/L thiamine hydrochloride, 1 g/L NH4Cl and 0.4% glycerol or 180 
glucose as appropriate) containing 100 µg/mL ampicillin and grown overnight at 37°C with 181 
shaking. The next morning, cultures were transferred to 96-well plate format with 200 µl per 182 
well. Using the Theonyx platform, the cells then underwent dilution into fresh M9 medium 183 
containing 100 µg/mL ampicillin at a cell density of 140 ng/µl (OD600 of 0.15 in the attached 184 
plate reader) in a total volume of 100 µl. This was followed by an outgrowth phase of 185 
approximately 2.5 h to allow cells to attain exponential growth.   Subsequently, 25 µl of 186 
sample were added. For characterisation, mock samples containing varying concentrations 187 
of L-lactate, D-lactate, or pyruvate (all Sigma Aldrich) were mixed in appropriate background 188 
solvent of M9 minimal medium, CD-CHO (Invitrogen, UK), CD-CHO + HT supplement 189 
(11067-030, Gibco) + 8 mM glutamine (Invitrogen, UK), DMEM (SIGMA, 51449C), DMEM 190 
containing phenol red (Sigma, D6546), or DMEM containing 10% (v/v) calf bovine serum 191 
(ATCC, 30-2030). For quantification of mammalian cell culture samples, culture supernatant 192 
taken from growing cultures described below were added and a standard curve containing 193 
known concentrations of lactate in the same background solution was included to create a 194 
transfer function from which lactate concentration was calculated. The OD600 and GFP 195 
fluorescence (λexcitation 485/20 nm, λemission 528/20 nm) were measured every 10 min. All cell 196 
growth and characterisation on the robotic platform was done at 37°C with shaking at 700 197 
rpm.  198 
Analysis of Biosensor Data and Calculation of Concentration Estimates 199 
Raw fluorescence data was processed in R 3.1.2 as follows. A spline interpolation was fit to 200 
each fluorescent time course to reduce the impact of equipment error on the values. To 201 
prevent over-fitting of the spline and ensure that the interpolation calculated was a strong 202 
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predictor of the original time course, an exhaustive cross validation was carried out to 203 
choose the ideal smoothening value for each. Leave-p out cross validation was used, where 204 
p=2.Subsequently, Microsoft Excel was used for linear regression of the fluorescence versus 205 
corrected OD600 of the control cells was used to fit an equation, which was used to subtract 206 
cellular autofluorescence from biosensor fluorescence measurements as follows: 207 
,	
 =  − (( ∗  +  
where m and c represent the slope and intercept of the trendline, respectively 208 
The fluorescence rate of change (GFP synthesis rate) was calculated by dividing the 209 
difference in fluorescence between adjacent time points by one half of the difference in 210 
OD600 between the same time points.  All samples were normalised to the biosensor cultures 211 
without addition of lactate.  The transfer functions were created using data from 150 min post 212 
addition of the sample to the biosensor cultures using the GraphPad Prism nonlinear 213 
regression (sigmoidal,4PL) function to fit the data. 214 
To compare the biosensors under different conditions, the fold-induction, goodness-of-fit of 215 
the transfer function, limit of detection, and sensitivity were calculated. All values were 216 
calculated at 150 minutes, except for the experiment where cells were grown directly in CD-217 
CHO medium, where 90 minutes was used due to lack of separation of the lactate 218 
concentrations at 150 minutes. The fold-induction was calculated as the fluorescence rate of 219 
change of samples containing 14 mM lactate divided by the fluorescence rate of change of 220 
samples with no added lactate.  The goodness-of-fit and the sensitivity (also called the ‘Hill 221 
slope’ or the gradient of the Hill function) were calculated using GraphPad Prism.  The limit 222 
of detection reported is the lowest lactate concentration that gave a response different from 223 
background at the 150 min timepoint. The actual lowest limit of detection may be lower, but 224 
was not tested here or appears at a different time point. 225 
To calculate lactate concentrations in mammalian cell culture samples, GFP synthesis rate 226 
values from a set of standards from the same experiment were chosen to make a standard 227 
curve and the GFP synthesis rate values from biosensors incubated with the cell culture 228 
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samples were used to interpolate (sigmoidal, 4PL) the lactate concentrations using the 229 
GraphPad Prism software. 230 
Mammalian cell culture 231 
Hybridoma flask cultures: ATCC-CRL1606 murine hybridoma, producing a mAb (HFN7.1) 232 
against human fibronectin were cultured in 500 ml Erlenmeyer  233 
flasks (Corning, UK) at 37°C in an atmosphere containing 5% CO2 on an orbital shaking 234 
platform rotating at 125 rpm. The basal growth medium was 100 ml glutamine-free DMEM 235 
(Sigma, D6546) supplemented with 10% (v/v) calf bovine serum (ATCC, 30-2030) and 0 mM 236 
-10 mM Gln (Sigma, G3126), which was sterilised by filtration. 237 
CHO-S flask cultures: The CHO-S cell line expressing a truncated glycosyltransferase-238 
ECFP-EYFP fusion protein was a kind gift from Antony Constantinou (CSynBI, Imperial 239 
College London). The CHO-S cells were cultured in a 250 ml Erlenmeyer flask (Corning, UK) 240 
at 37°C in an atmosphere containing 5% CO2 on an orbital shaking platform rotating at 125 241 
rpm. The basal growth medium was 100 ml CD-CHO medium (Invitrogen,UK), 242 
supplemented with 8 mM glutamine (Invitrogen, UK) and 1X HT supplement (11067-030, 243 
Gibco). 244 
GS-CHO bioreactor cultures: The GS-CHO 46 cell line, kindly provided by Lonza Biologics 245 
(Slough, U.K.), was cultured at 140 rpm in humidified 37°C incubator with 8% CO2 supply. 246 
Cells were sub-cultured in fresh CD-CHO medium (Life Technologies, Paisley, UK) every 247 
three days at a seeding density of 2x105 viable cells/mL and transferred into the bioreactor 248 
system on the fourth cell passage. 25 µM L-Methionine sulfoximine (MSX) (Sigma-Aldrich, 249 
Dorset, UK) was added to the medium in first and second passages only.  250 
The 3L Mobius® CellReady bioreactor (EMD Millipore, Bedford, MA) was inoculated at a 251 
seeding density of 3 x 105 cells/mL in an initial culture volume of 1.2 L. The culture was 252 
mixed using an in-house up-pumping marine impeller rotating at 100 rpm. The culture was 253 
controlled with the my-control unit (Applikon Biotechnology, Schiedam, Netherlands) at a 254 
temperature of 37 ± 0.5°C using a heating blanket, and at a pH of 7.0 ± 0.1 using CO2 255 
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supplementation and 100 mM NaHCO3/ 100 mM Na2CO3 alkali solution (Sigma-Aldrich, 256 
Dorset, UK). Dissolved oxygen tension (DOT) was set at a minimum of 30% with oxygen 257 
supply. Culture temperature, pH and DOT were monitored online using BioExpert software, 258 
version 1.1X (Applikon Technology, Schiedam, Netherlands). The culture was supplemented 259 
with CD EfficientTM Feed C AGTTM (Life Technologies, Paisley, UK) at 10% of culture volume 260 
on alternate days starting from day 2. 5% w/v antifoam C (Sigma-Aldrich, Dorset, UK) was 261 
added when foaming was observed. The working volume was maintained between 1.0 and 262 
1.3 L by drawing out excess culture fluid. The cell culture was harvested on day 16.  263 
Cross validation of lactate concentration 264 
Samples of 1-5 ml as required were taken from the culture, the cells were removed by 265 
centrifugation at 800 rpm for 5 minutes and the supernatant transferred to a fresh tube and 266 
stored at -20°C before further analysis. The Bioprofile® 400 Analyzer (Nova Biomedical) was 267 
used to measure ammonia, glucose, glutamine, glutamate and lactate concentrations 268 
according to the manufacturer's guidelines. Lactate concentrations in samples were also 269 
analysed using a colourimetric, enzymatic lactate kit (MAK064, Sigma) according to the 270 
manufacturer's instructions. 271 
Results  272 
Initial testing of biosensor designs 273 
We designed and constructed two whole-cell lactate biosensors (Figure 2) and compared 274 
their performance in samples of M9 minimal medium with glycerol as the carbon source 275 
spiked with different concentrations of L-lactate. The first biosensor expressed green 276 
fluorescent protein (GFP) under the control of the lldPRD promoter (Aguilera et al. 2008). 277 
Characterisation of this construct showed a very limited lactate response (Figure 2a, Table 278 
1) with only 2-fold induction and a high level of leaky expression in the absence of lactate.  279 
For example, the fluorescence rate of change of the biosensor at 150 minutes is 1402.8 280 
arbitrary units versus 25.3 arbitrary units in the improved biosensor design discussed below 281 
(data not shown), indicating that the genomically-expressed lldR is not sufficient to repress 282 
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reporter expression in the absence of inducer. Negative values for fluorescence and GFP 283 
synthesis rates result from the data analysis procedure where values are normalised to the 284 
biosensor cultures with no added lactate.  In the case of this biosensor design, low 285 
concentrations of lactate are not distinguishable from zero lactate and, by random chance, 286 
can give fluorescence values below that of the culture without added lactate. 287 
An improved version of the biosensor contained an additional module overexpressing the 288 
lldR transcription factor under a constitutive promoter in order to lower the baseline GFP 289 
expression. Characterisation of this biosensor in M9 minimal medium with added lactate 290 
showed a clear lactate response with good separation between different concentrations 291 
(Figure 2b, Table 1).  The new biosensor had a 60-fold induction and a lower limit of 292 
detection that was an order of magnitude lower. Thus, the version of the biosensor with the 293 
additional module for overexpression of lldR was used in all further studies. 294 
The biosensor sensitivity to the growth environment was also tested (Supplementary Figure 295 
1a, Table 1).  When cells were grown in M9 minimal medium with glucose instead of glycerol 296 
as the carbon source, the biosensor is still able to detect lactate with very similar lower limit 297 
of detection.  However, the induction of the response is nearly 70% lower suggesting the 298 
environment does influence sensing capabilities. 299 
We also analysed the biosensor response to two structurally similar metabolites. The 300 
biosensor was found to show a very small response to D-lactate (Supplementary  Figure 1b, 301 
Table 1) with a sensitivity decreased by 91% and a lower limit of detection of 0.5 mM. 302 
However, its response to pyruvate was within the inherent measurement error and therefore 303 
negligible (Supplementary Figure 1c, Table 1).  It is possible that the response to D-lactate is 304 
due to small amounts of L-lactate contamination in the D-lactate, which is only 99% pure.  305 
The fact that the biosensor can distinguish between L-lactate and pyruvate is important for 306 
cell culture studies where pyruvate is often present either as a medium additive or additional 307 
metabolite produced by the mammalian cells during metabolism. 308 
Developing a workflow for quantification 309 
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When biosensor cells were cultured directly in CD-CHO, a widely used chemically defined 310 
mammalian cell culture medium, the lower limit of detection was decreased by a factor of 4 311 
and the GFP synthesis profile showed only a short burst which quickly returned to baseline 312 
(Supplementary Figure 2a), most likely due to the rapid growth rate of the cells in this 313 
medium. In contrast to the robust signals in M9 medium, the low signal-to-noise ratio of cells 314 
cultured in CD-CHO (fold induction of 2.8 versus 60, Figure 3A, Table 1) made it difficult to 315 
distinguish between low concentrations of lactate.  This is analogous to the observations of 316 
Courbet et al. where signals were damped in urine and serum due to the complexity of the 317 
medium (Courbet et al. 2015). Although CD-CHO is chemically defined, it contains more 318 
than 70 different compounds in its formulation (European Patent Application, EP 1 482 031 319 
A1, 2004) including sugars, amino acids, and lipids. 320 
Therefore, we developed a workflow where the biosensor cells were initially cultured in M9 321 
medium and a mock sample of mammalian cell culture medium supplemented with a known 322 
concentration of lactate was added to the cells.  By minimising the volume of the cell culture 323 
sample to 20% of the total volume (5-fold dilution), the biosensor cells were able to detect 324 
lactate spiked into CD-CHO medium (Figure 3b, Table 1), CD-CHO medium containing HT 325 
supplement and glutamine (Figure 3c, Table 1), Dulbecco’s Modified Eagle Medium (DMEM) 326 
(Figure 3d), DMEM containing the pH indicator phenol red (Figure 3e, Table 1) and DMEM 327 
containing 10% serum, a common culture additive (Figure 3f, Table 1). Although the 328 
dynamic (Supplementary Figure 2a-f) and static (Figure 3a-f) response of the biosensor to 329 
lactate changes in different media, a lactate response is always measurable, and therefore, 330 
quantifiable using a standard curve.  331 
In all conditions, the lactate response initially increases, but levels off over time. Further 332 
investigation suggests that this is as a result of lactate concentration in the biosensor 333 
cultures decreasing over time (Supplementary Figure 3), most likely due to lactate being 334 
taken up and metabolised by the bacterial cells as part of the sensing process.  The E. coli 335 
strain used as a biosensor host retains the genomic copy of LldP (lactate permease) and 336 
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LldD (lactate dehydrogenase), which allow for the transport and utilisation of lactate, 337 
respectively, by the biosensor cells when the operon expression is induced (Figure 1). 338 
Utility Testing with Cell Culture Samples and Cross Validation 339 
We then undertook a series of cell culture experiments to see if the biosensor could be used 340 
to quantify lactate metabolism in real cultures.  When cells are inoculated into the medium, 341 
they use the nutrients provided, grow, produce additional metabolites, and express 342 
recombinant protein, further increasing the complexity of the sample.  To test the 343 
performance of the biosensor in a range of industrial conditions, we used three experimental 344 
scenarios: (i)  hybridoma cells grown in shake flasks in DMEM containing phenol red and 345 
supplemented with 10% serum and different concentrations of glutamine in the medium to 346 
optimise antibody expression level, mimicking the type of medium optimisation experiment 347 
that is commonly employed in industry,(ii) a CHO-S cell line expressing a fusion protein  348 
grown in batch culture in CD-CHO medium in shake flasks, and (iii) a GS-CHO cell line 349 
expressing a monoclonal antibody grown in a fed-batch bioreactor with CD-CHO medium 350 
and fed with CD EfficientTM Feed C AGTTM on alternate days beginning on day 2.  Samples 351 
were taken over time and simultaneously analysed using our biosensor workflow, the 352 
Bioprofile® Analyzer, and a lactate oxidase enzymatic assay to enable cross validation of the 353 
results (Figure 4a). 354 
Significantly, our results show that the biosensor can accurately determine lactate 355 
concentrations in samples from a range of different conditions relevant to the 356 
biopharmaceutical industry (Figures 4b-4d, Table 1). Figure 4b shows a snapshot of lactate 357 
concentration after 100 hours of hybridoma culture in DMEM supplemented with different 358 
concentrations of glutamine.  Similar types of experiments are done in industry to optimise 359 
the formulation of media. Cell number and antibody production vary across the media with 360 
different glutamine concentrations (Supplementary Figure 4) leading to different sample 361 
backgrounds, yet the biosensor accurately quantifies the extracellular concentration of 362 
lactate when compared with the other assay methods.  Similarly, the biosensor provides 363 
accurate quantification of lactate accumulation over time in batch culture of CHO-S in shake 364 
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flasks (Figure 4c, Table 1) despite changing concentrations of other metabolites 365 
(Supplementary Figure 5). Finally, samples from GS-CHO cell cultures grown in fed-batch 366 
bioreactor (Figure 4d, Table 1) accumulated much higher concentrations of extracellular 367 
lactate over the course of a 16 day culture, which when combined with pH control would lead 368 
to very high osmolarity of the samples (Supplementary Figure 6). Nonetheless, quantification 369 
with the biosensor was in good agreement with the other two methods, except for the final 370 
sample from 16 days of culture, where the biosensor overestimated the concentration of 371 
lactate by a factor of ~1.5 compared to the average value from the two established methods 372 
(Figure 4d). This overestimate is likely due to the effects of high osmolarity ( > 700 mmol/L) 373 
on cells. Indeed antibody titres have actually decreased on day 16 compared to their 374 
maximum at day 12 (Supplementary Figure 6), suggesting significant amounts of cell lysis 375 
have occurred, which would vastly increase the complexity of the sample.  Overall, our 376 
biosensor has a lower limit of detection for lactate than the BioProfile® Analyzer, which is the 377 
current method of choice for metabolite analysis of bioprocessing samples in industry. It is 378 
able to measure lactate concentrations as low as 50 µM in M9 medium, which is 379 
approximately 100-fold lower than the lower limit of detection of the BioProfile® Analyzer. 380 
Even when samples are in complex backgrounds such as CD-CHO or DMEM with phenol 381 
red, the lower limit of detection was still 100 µM. 382 
Discussion  383 
We have created a functional whole-cell lactate biosensor based on the E. coli lldPRD 384 
operon and have demonstrated that this biosensor can be used for monitoring lactate in 385 
complex industrial contexts, specifically mammalian cell cultures producing a recombinant 386 
protein, with high accuracy and a lower limit of detection than the industry standard method. 387 
In fact, our biosensor was able to detect lactate at a concentration up to two orders of 388 
magnitude lower than the Bioprofile analyser (100 µM versus 1-2 mM) in samples from real 389 
cell cultures. To our knowledge this is the first demonstration of robust quantification of 390 
samples in complex backgrounds using a whole-cell biosensor.  In addition, our biosensor 391 
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has a cheaper cost per sample analysed than the commercial lactate oxidase enzyme assay 392 
kit at (approximately 3% of the cost at £13 versus £403.50 per 96-well plate analysed, 393 
Supplementary Methods). 394 
The work described here capitalises on the synthetic biology principles of automation and 395 
characterisation.  We used iterative cycles of characterisation of biosensor behaviour in 396 
increasingly complex conditions to develop a workflow for robust quantification of 397 
metabolites in real samples.  The workflow we developed can serve as a blueprint for 398 
developing whole-cell biosensors for other metabolites, many of which are important in 399 
health and disease (Wishart 2016), as well as industrial contexts.  In this respect, we have 400 
shown that biosensors need not be limited to sensing exogenous compounds, which will 401 
enable biologists to fully capitalise on the wealth of natural operons available for biosensing 402 
to design biosensors for broader variety of compounds.  Automation is useful to increase the 403 
reproducibility of measurements, permit the detection of small responses, and facilitate the 404 
comparison of datasets across different experiments.  We also found that culturing the cells 405 
in a single base medium (M9 medium) and adding samples of interest gives more robust 406 
growth dynamics and better detection ability across many different kinds of samples. 407 
Our whole-cell lactate biosensor can be applied towards a broad range of biological 408 
questions, as lactate is widely used in the food and pharmaceutical industries, and also in 409 
the production of polylactic acid, a biodegradable plastic alternative made from renewable 410 
resources (Wang et al. 2015). It is also an important clinical biomarker for altered 411 
metabolism and many physiological conditions, including inflammation (Haas et al. 2015), 412 
cardiovascular diseases (Zhang et al. 2015) and cancer (San Martin et al. 2013; 413 
Vlachostergios et al. 2015).  Finally, in combination with advances in 3D printing of cells 414 
(Cao et al. 2016), we envision that the biosensor could also be used to gain spatial 415 
information from adherent cell cultures, which would facilitate the detection of differences in 416 
metabolism within individual cells, potentially enabling the diagnosis of diseases such as 417 
cancer, artherosclerosis, and diabetes based on metabolic signatures within cells (Galluzzi 418 
et al. 2013; Wishart 2016).  419 
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Nomenclature 428 
CD-CHO- Chemically defined medium for Chinese Hamster Ovary cell lines 429 
CHO- Chinese Hamster Ovary cells 430 
DMEM-  Dulbecco’s Modified Eagle Medium 431 
GFP- Green Fluorescent Protein 432 
HPLC- High Performance Liquid Chromatography 433 
MSX- L-Methionine sulfoximine  434 
PBS- Phosphate buffered saline  435 
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List of Figures and Figure Legends 610 
Figure 1: Schematic of the LldPRD operon and biochemical mechanism (a) 611 
Organisation of the lldPRD operon. O1 and O2 represent the operator sites in the  lldPRDp 612 
promoter. The three genes in the operon are (from left to right) LldP: lactate permease to 613 
allow lactate transport, LldR: regulatory protein, LldD: lactate dehydrogenase for lactate 614 
utilisation. (b) Diagram of the mechanism of lactate-dependent induction of lldPRD operon in 615 
E. coli cells. Top: In the absence of lactate, dimers of LldR bind to the operator sites in the 616 
lldPRDp promoter and form a tetramer, sequestering the DNA and preventing transcription 617 
of the operon.   Bottom: Lactate enters the cell via the glycolate permease (GlcA) or LldP 618 
and interacts with the LldR regulator protein.  The LldR dimer bound to O2 dissociates when 619 
bound to lactate, but the dimer bound to O1 becomes a transcriptional activator that 620 
promotes transcription of the operon when lactate binds. 621 
Figure 2: Characterisation of two different biosensor designs (a) Biosensor without 622 
overexpression of LldR (b) Biosensor with constitutive overexpression of LldR regulator. In 623 
each panel: (Top): Diagram of the genetic construct. (Bottom): Characterisation data at 624 
different concentrations of lactate: Fluorescence normalised by OD600, Fluorescence rate of 625 
change, and Transfer function from data at 150 minutes.  Error bars represent the standard 626 
deviation of 6 measurements (2 technical replicates of 3 biological replicates). The negative 627 
fluorescence and fluorescence rate of change values are a result of the normalisation of data 628 
to the biosensor culture without added lactate. 629 
Figure 3: Measurement of lactate in mammalian cell culture media (a) Biosensor 630 
response to L-lactate when grown in CD-CHO medium. (b-f) Biosensor response to L-lactate 631 
spiked into different mammalian cell culture media (b) CD-CHO medium, (c) CD-CHO 632 
medium with added HT supplement and 8 mM glutamine, (d) DMEM medium, (e) DMEM 633 
medium with added phenol red, (f) DMEM medium with added serum. Data are presented as 634 
transfer functions from data at 150 minutes. For the time course data please see 635 
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Supplementary Figure 2. Error bars indicate the standard deviation of 6 measurements (2 636 
technical replicates each of 3 biological replicates). 637 
Figure 4: Quantitative analysis of cell culture samples using lactate biosensor with 638 
cross-validation against existing methods. (a) Experimental workflow. Samples were 639 
collected from mammalian cell cultures and analysed for lactate content using the lactate 640 
biosensor (blue), a BioProfile® Analyzer (green) and a lactate oxidase enzymatic assay 641 
(orange). (b) Samples from CRL1606 hybridoma cultures in DMEM containing phenol red 642 
and 10% serum. Six hybridoma cultures were run in parallel with varying starting 643 
concentrations of glutamine starting as indicated in order to maximise antibody titre. The 644 
samples shown here were collected after 100 h of mammalian cell culture. (c) Time course 645 
samples from a CHO-S batch shake flask culture in CD-CHO medium supplemented with 1X 646 
HT supplement and 8 mM glutamin . (d) Time course samples from a GS-CHO fed-batch 647 
bioreactor culture in CD-CHO supplem nted with Feed C every two days.  Error bars 648 
indicate the standard deviation of 6 measurements (2 technical replicates each of 3 649 
biological replicates) for biosensor measurements, 2 technical replicates for the enzyme 650 
assays and a single measurement for the BioProfile® Analyzer. For further metabolite data 651 
for these mammalian cell cultures please see Supplementary Figures 4-6.  Missing values 652 
are below the limit of detection of the BioProfile® Analyzer. 653 
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Figure 1: Schematic of the LldPRD operon and biochemical mechanism (a) Organisation of the lldPRD 
operon. O1 and O2 represent the operator sites in the  lldPRDp promoter. The three genes in the operon are 
(from left to right) LldP: lactate permease to allow lactate transport, LldR: regulatory protein, LldD: lactate 
dehydrogenase for lactate utilisation. (b) Diagram of the mechanism of lactate-dependent induction of 
lldPRD operon in E. coli cells. Top: In the absence of lactate, dimers of LldR bind to the operator sites in the 
lldPRDp promoter and form a tetramer, sequestering the DNA and preventing transcription of the 
operon.   Bottom: Lactate enters the cell via the glycolate permease (GlcA) or LldP and interacts with the 
LldR regulator protein.  The LldR dimer bound to O2 dissociates when bound to lactate, but the dimer bound 
to O1 becomes a transcriptional activator that promotes transcription of the operon when lactate binds.  
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Figure 2: Characterisation of two different biosensor designs (a) Biosensor without overexpression of LldR 
(b) Biosensor with constitutive overexpression of LldR regulator. In each panel: (Top): Diagram of the 
genetic construct. (Bottom): Characterisation data at different concentrations of lactate: Fluorescence 
normalised by OD600, Fluorescence rate of change, and Transfer function from data at 150 minutes.  Error 
bars represent the standard deviation of 6 measurements (2 technical replicates of 3 biological replicates). 
The negative fluorescence and fluorescence rate of change values are a result of the normalisation of data to 
the biosensor culture without added lactate.  
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Figure 3: Measurement of lactate in mammalian cell culture media (a) Biosensor response to L-lactate when 
grown in CD-CHO medium. (b-f) Biosensor response to L-lactate spiked into different mammalian cell 
culture media (b) CD-CHO medium, (c) CD-CHO medium with added HT supplement and 8 mM glutamine, 
(d) DMEM medium, (e) DMEM medium with added phenol red, (f) DMEM medium with added serum. Data 
are presented as transfer functions from data at 150 minutes. For the time course data please see 
Supplementary Figure 2. Error bars indicate the standard deviation of 6 measurements (2 technical 
replicates each of 3 biological replicates).  
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Figure 4: Quantitative analysis of cell culture samples using lactate biosensor with cross-validation against 
existing methods. (a) Experimental workflow. Samples were collected from mammalian cell cultures and 
analysed for lactate content using the lactate biosensor (blue), a BioProfile® Analyzer (green) and a lactate 
oxidase enzymatic assay (orange). (b) Samples from CRL1606 hybridoma cultures in DMEM containing 
phenol red and 10% serum. Six hybridoma cultures were run in parallel with varying starting concentrations 
of glutamine starting as indicated in order to maximise antibody titre. The samples shown here were 
collected after 100 h of mammalian cell culture. (c) Time course samples from a CHO-S batch shake flask 
culture in CD-CHO medium supplemented with 1X HT supplement and 8 mM glutamine. (d) Time course 
samples from a GS-CHO fed-batch bioreactor culture in CD-CHO supplemented with Feed C every two 
days.  Error bars indicate the standard deviation of 6 measurements (2 technical replicates each of 3 
biological replicates) for biosensor measurements, 2 technical replicates for the enzyme assays and a single 
measurement for the BioProfile® Analyzer. For further metabolite data for these mammalian cell cultures 
please see Supplementary Figures 4-6.  Missing values are below the limit of detection of the BioProfile® 
Analyzer.  
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Supplementary Tables 
Supplementary Table 1: Sequence of LldR promoter 
Promoter  Sequence 
lldPRD promoter  
 
CTTTACCAG ACATCTCCCC CCACAAGAAT TGGCCCTACC 
AATTCTTCGC TTATCTGACC TCTGGTTCAC AATTTCCCAA 
TTAAAACTCA CATCAATGTT GCCAATACAT AACATTTAGT 
TAACCATTCA TTGTCATTAT CCCTACACAA CACAATTGGC 
AGTGCCACTT TTACACAACG TGTGACAAGG AGATGAGCAA 
CAGACTCATT ACACGATGTG CGTGGACTCC 
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Supplementary Table 2: Primers used for amplification and cloning of LlDR operon 
components 
Primer Sequence 
LldR Forward ATGATTGTTTTACCCAGACGC 
LldR Reverse TCATGCGTTTTTCTCCCTCG 
LldR BioBrick 
Forward 
GTTTCTTCGAATTCGCGGCCGCTTCTAGAGATGATTGTTTTACCCAG
ACGC 
LldR Biobrick 
Reverse 
TACTAGTAGCGGCCGCTGCAGGAAGAAACTCATGCGTTTTTCTCCCT
CG 
LldR Promoter 
Forward 
CTTTACCAGACATCTCCCCCCAC 
LldR Promoter 
Reverse 
GGAGTCCACGCACATCGTGTAATG 
LldR Promoter 
BioBrick 
Forward 
GTTTCTTCGAATTCGCGGCCGCTTCTAGAGCTTTACCAGACATCTCC
CCCCAC 
LldR Promoter 
BioBrick 
Reverse 
TACTAGTAGCGGCCGCTGCAGGAAGAAACGGAGTCCACGCACATC
GTGTAATG 
Bold indicates BioBrick Prefix and Suffix 
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Supplementary Methods: Cost comparison of Biosensor and Lactate Oxidase Assay 
The list price of the lactate oxidase assay kit (Sigma Aldrich, MAK064) was £403.50 on 
09/11/2016.  The kit will analyse 96 samples (including controls) 
For the biosensor assay, for one 96-well plate assay (including controls), the costs included 
are overnight growth of the biosensor in LB (£1.31) containing 100 µg/mL ampicillin (£0.02), 
followed by dilution into M9 medium  (£0.31) plus ampicillin (£0.04) and IPTG (£0.71), and 
assay, which uses special tips for the liquid handling system (£10.74) for a total cost of 
£12.95.  The calculation of the M9 costs are shown in Supplementary Table 3. Each assay 
requires 128 mL of M9 medium for cell growth before sample addition.  All chemical prices 
were taken from the list price of the manufacturer on 09/11/2016 for the product number 
given in the table.  
 Both assays require a 96-well plate with clear bottom, the cost of which has been omitted 
because it is equal in both assays. 
Supplementary Table 3: Calculation of M9 medium costs 
 
 
 
  
M9 ingredients amount in 1 L brand price price/1L of M9 price/145 ml of M9
M9 salts 11.28g Formedium £62.5/1kg 0.71 0.10
Ammonium chloride 1g Sigma Aldrich, A9434 £25/500g 0.05 0.01
thiamine hydrochloride 0.34g Sigma Aldrich, T4625 £14.6/5g 0.99 0.14
CaCl2 0.01g Sigma Aldrich, C1016 £26.4/500g 0.00 0.00
MgSO4 0.24g Sigma Aldrich, M7506 £43.10/500g 0.02 0.00
glycerol 4ml Sigma Aldrich, G5516 £90.3/1L 0.36 0.05
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Supplementary Figure Captions 
Supplementary Figure 1: Additional lactate biosensor characterisation data (a) 
Biosensor response to L-lactate in M9 medium containing glucose as the carbon source. (b) 
Biosensor response to D-lactate. (c) Biosensor response to pyruvate. Left: Fluorescence 
normalised by OD600 Middle: Fluorescence rate of change Right: Transfer function from 
data at 150 minutes. Error bars represent the standard deviation of 6 measurements (2 
technical replicates of 3 biological replicates). 
Supplementary Figure 2: Time course analysis of biosensor in different mammalian 
cell culture media. (a) Biosensor response to L-lactate when grown in CD-CHO medium. 
(b-f) Biosensor response to L-lactate spiked into different mammalian cell culture media (b) 
CD-CHO medium, (c) CD-CHO medium with added HT supplement and 8 mM glutamine, (d) 
DMEM medium, (e) DMEM medium with added phenol red, (f) DMEM medium with added 
serum. Left: Fluorescence normalised by OD600 Right: Fluorescence rate of change. Error 
bars indicate the standard deviation of 6 measurements (2 technical replicates each of 3 
biological replicates). 
Supplementary Figure 3: Lactate concentration changes over time in biosensor 
cultures with different starting lactate concentrations. Samples were taken at the 
indicated times after addition of L-lactate and the concentration was measured using the 
lactate oxidase assay.  Error bars represent the standard deviation of 2 technical replicates. 
Supplementary Figure 4: Additional metabolite, cell growth, and antibody production 
data for hybridoma cell cultures supplemented with different amounts of glutamine. 
(a) Viable cell concentration. (b) Percentage cell viability. (c) Integral viable cell 
concentration.  (d) Relative antibody titre after 100 hours of culture normalised to the 
antibody titre for the culture that was not supplemented with glutamine. (e-h) Extracellular 
metabolite data (e) Glutamine. (f) Ammonia. (g) Glucose. (h) Lactate. Metabolites were 
measured using a BioProfile® Analyzer and cells were counted using the trypan blue method 
and a haemocytometer. Relative mAb concentration was measured using an ELISA. Missing 
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values were above or below the limit of detection of the BioProfile® Analyzer. Error bars for 
mAb represent the standard deviation of 3 technical replicates.  
Supplementary Figure 5: Cell growth and metabolite data for the CHO-S batch flask 
culture. Metabolites were measured using a BioProfile® Analyzer and cells were counted 
using the trypan blue method and a haemocytometer.  
Supplementary Figure 6: Metabolite and osmolarity data for GS-CHO fed-batch 
bioreactor culture. Metabolites were measured using a BioProfile® Analyzer and osmolarity 
was calculated from the following equation: Osm= 1.86([Na+] + [K+] + [NH4+]) + [Glutamate]/ 
0.18 + [Lactate]/ 0.096 + constant. Missing values were above or below the limit of detection 
of the BioProfile® Analyzer.  
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Supplementary Figure 1: Additional lactate biosensor characterisation data (a) Biosensor response to L-
lactate in M9 medium containing glucose as the carbon source. (b) Biosensor response to D-lactate. (c) 
Biosensor response to pyruvate. Left: Fluorescence normalised by OD600 Middle: Fluorescence rate of 
change Right: Transfer function from data at 150 minutes. Error bars represent the standard deviation of 6 
measurements (2 technical replicates of 3 biological replicates).  
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Supplementary Figure 2: Time course analysis of biosensor in different mammalian cell culture media. (a) 
Biosensor response to L-lactate when grown in CD-CHO medium. (b-f) Biosensor response to L-lactate 
spiked into different mammalian cell culture media (b) CD-CHO medium, (c) CD-CHO medium with added 
HT supplement and 8 mM glutamine, (d) DMEM medium, (e) DMEM medium with added phenol red, (f) 
DMEM medium with added serum. Left: Fluorescence normalised by OD600 Right: Fluorescence rate of 
change. Error bars indicate the standard deviation of 6 measurements (2 technical replicates each of 3 
biological replicates).  
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Supplementary Figure 3: Lactate concentration changes over time in biosensor cultures with different 
starting lactate concentrations. Samples were taken at the indicated times after addition of L-lactate and the 
concentration was measured using the lactate oxidase assay.  Error bars represent the standard deviation of 
2 technical replicates.  
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Supplementary Figure 4: Additional metabolite, cell growth, and antibody production data for hybridoma cell 
cultures supplemented with different amounts of glutamine. (a) Viable cell concentration. (b) Percentage cell 
viability. (c) Integral viable cell concentration.  (d) Relative antibody titre after 100 hours of culture 
normalised to the antibody titre for the culture that was not supplemented with glutamine. (e-h) 
Extracellular metabolite data (e) Glutamine. (f) Ammonia. (g) Glucose. (h) Lactate. Metabolites were 
measured using a BioProfile® Analyzer and cells were counted using the trypan blue method and a 
haemocytometer. Relative mAb concentration was measured using an ELISA. Missing values were above or 
below the limit of detection of the BioProfile® Analyzer. Error bars for mAb represent the standard deviation 
of 3 technical replicates.  
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Supplementary Figure 5: Cell growth and metabolite data for the CHO-S batch flask culture. Metabolites 
were measured using a BioProfile® Analyzer and cells were counted using the trypan blue method and a 
haemocytometer.  
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Supplementary Figure 6: Metabolite and osmolarity data for GS-CHO fed-batch bioreactor culture. 
Metabolites were measured using a BioProfile® Analyzer and osmolarity was calculated from the following 
equation: Osm= 1.86([Na+] + [K+] + [NH4+]) + [Glutamate]/ 0.18 + [Lactate]/ 0.096 + constant. Missing 
values were above or below the limit of detection of the BioProfile® Analyzer.  
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Nature has evolved highly sensitive genetic detection elements that can be exploited to create low-cost 
whole-cell biosensors (WCB).  Using lactate as an example, we show that it is possible to use WCB not just 
for detection, but also for quantification of concentration in complex samples such as mammalian cell culture 
media with a high degree of accuracy and greater sensitivity than the industry standard method.  The 
results pave the way for the application of WCB in industrial bioprocess development.  
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